Quarterly report pursuant to Section 13 or 15(d)

Financial Instruments (Tables)

v3.22.1
Financial Instruments (Tables)
3 Months Ended
Mar. 31, 2022
Investments All Other Investments [Abstract]  
Schedule of Cash and Cash Equivalents As of March 31, 2022, the Company’s cash and cash equivalents were as follows:

 

 

 

 

 

 

Gross

 

 

 

 

 

 

Cash and

 

 

 

 

 

 

 

Unrealized

 

 

Fair

 

 

Cash

 

 

 

Cost

 

 

Losses

 

 

Value

 

 

Equivalents

 

Cash

 

$

236,524

 

 

$

 

 

$

236,524

 

 

$

236,524

 

Level 1:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Money market funds

 

 

1,029

 

 

 

 

 

 

1,029

 

 

 

1,029

 

Total

 

$

237,553

 

 

$

 

 

$

237,553

 

 

$

237,553

 

 

As of December 31, 2021, the Company’s cash and cash equivalents balances were as follows:

 

 

 

 

 

 

Gross

 

 

 

 

 

 

Cash and

 

 

 

 

 

 

 

Unrealized

 

 

Fair

 

 

Cash

 

 

 

Cost

 

 

Losses

 

 

Value

 

 

Equivalents

 

Cash

 

$

253,693

 

 

$

 

 

$

253,693

 

 

$

253,693

 

Level 1:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Money market funds

 

 

1,029

 

 

 

 

 

 

1,029

 

 

 

1,029

 

Total

 

$

254,722

 

 

$

 

 

$

254,722

 

 

$

254,722

 

 

Schedule of Contingent Consideration Liabilities Current and Non-current Balances

As of March 31, 2022, the Company’s contingent consideration liabilities current and non-current balances were as follows:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Changes in

 

 

Amount Paid

 

 

 

 

Fair

 

 

Contingent

 

 

 

Cost

 

 

Fair Value

 

 

In Period

 

 

 

 

Value

 

 

Consideration

 

Level 3:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Contingent consideration, current

 

$

18,017

 

 

$

2,933

 

 

$

(20,816

)

 

 

 

$

134

 

 

$

134

 

Contingent consideration, non-current

 

 

8,383

 

 

 

27,033

 

 

 

 

 

 

 

 

35,416

 

 

 

35,416

 

Total

 

$

26,400

 

 

$

29,966

 

 

$

(20,816

)

 

 

 

$

35,550

 

 

$

35,550

 

 

As of December 31, 2021, the Company’s contingent consideration liabilities current and non-current balances were as follows:

 

 

 

 

 

 

 

Changes in

 

 

Fair

 

 

Contingent

 

 

 

Cost

 

 

Fair Value

 

 

Value

 

 

Consideration

 

Level 3:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Contingent consideration, current

 

$

18,017

 

 

$

1,971

 

 

$

19,988

 

 

$

19,988

 

Contingent consideration, non-current

 

 

8,383

 

 

 

16,354

 

 

 

24,737

 

 

 

24,737

 

Total

 

$

26,400

 

 

$

18,325

 

 

$

44,725

 

 

$

44,725